Table 3.

Patients with positive genetic testing

Sex	Age	Race	Ashkenazi	Mutation	Syndrome	Syndromic Manifestations	FH Kidney Cancer	Kidney Tumor
M	34	Caucasian	+	VHL	VHL	Retinal angiomas, epididymal cysts	+	ccRCC
F	56	Caucasian	−	VHL	VHL	Retinal angiomas	+	ccRCC
M	46	Hispanic	−	VHL	VHL	Cerebellar hemangioblastoma, Pancreatic Cyst	−	ccRCC
M	24	Caucasian	−	FH	HLRCC	None	+	Mixed RCC with papillary features
F	32	Hispanic	−	FH	HLRCC	Fibroids, Skin Lesions	−	Papillary RCC, Type II
M	61	Caucasian	−	FH	HLRCC	None	+	Collecting Duct RCC
M	42	Hispanic	−	FH	HLRCC	None	−	Collecting Duct RCC
M	34	Asian	−	FH	HLRCC	Tongue Papules	+	Unclassified RCC
F	62	African American	−	BHD	BHD	Lung Cysts	+	Chromophobe RCC
M	18	Caucasian	−	SDHB	Paraganglioma	None	+	ccRCC, Paraganglioma
F	24	Other	−	TSC1	Tuberous Sclerosis	Cephalgia	+	Papillary RCC, Unclassified RCC, AML
F	71	Caucasian	−	MLH1	Lynch Syndrome	None	−	UTUC
M	71	Caucasian	+	MSH2	Lynch Syndrome	Colonic polyps	+	UTUC
M	62	Asian	−	MSH2	Lynch Syndrome	None	−	UTUC
F	65	Caucasian	−	MSH6	Lynch Syndrome	None	−	ccRCC
F	57	Asian	−	MSH2	Lynch Syndrome	Fibroids	+	UTUC
F	45	Caucasian	−	MSH2	Lynch Syndrome	Colon Polyps	−	UTUC
F	44	Caucasian	−	MSH2	Lynch (Muir-Torre)	Sebaceous adenoma	−	UTUC
M	55	Caucasian	−	MSH2	Lynch (Muir-Torre)	Sebaceous adenoma	+	UTUC
F	64	Caucasian	−	MSH2	Lynch (Muir-Torre)	Keratoacanthoma, Sebaceous Adenoma	−	UTUC
F	64	Caucasian	−	RET	MEN2a	None	−	ccRCC
M	1	Caucasian	−	p53	Li-Fraumeni	None	−	Wilms, ccRCC
F	62	Caucasian	+	BRCA1	Breast Ovarian	None	−	RCC
M	49	Caucasian	+	BRCA2	Breast Ovarian	None	−	ccRCC
F	59	Caucasian	+	BRCA1	Breast Ovarian	None	−	ccRCC
F	36	Caucasian	+	BRCA1	Breast Ovarian	Infertility	−	ccRCC
M	48	Caucasian	+	BRCA2	Breast Ovarian	None	−	ccRCC